Published in J Virol on January 01, 1979
Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am J Pathol (1987) 1.22
17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription. Virology (2013) 0.89
A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst (1973) 10.64
Enhancing effect of cortisone upon poliomyelitis infection (Strain MEF1) in hamsters and mice. Proc Soc Exp Biol Med (1950) 3.53
Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem (1973) 2.58
Effect of Estrogen and Other Steroids on MM Virus Infection in Mice. Infect Immun (1970) 1.46
A versatile composite gel column for the electrophoretic separation of ribonucleic acid molecules. Prep Biochem (1971) 1.13
Nucleic acid of rubella virus and its replication in hamster kidney cells. J Virol (1970) 1.11
Mechanism of action of the sex steroid hormones (third of three parts). N Engl J Med (1976) 0.85
Further studies on the influence of steroids on viral infection in mice. Infect Immun (1973) 0.84
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 4.61
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
West Nile virus: a reemerging global pathogen. Emerg Infect Dis (2001) 3.27
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93
West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol (2000) 1.85
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology (1982) 1.80
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology (1985) 1.62
Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol (1982) 1.60
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
Monoclonal antibodies against the flavivirus West Nile. J Gen Virol (1982) 1.33
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay. J Clin Microbiol (1987) 1.29
Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus. Virology (1980) 1.28
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology (1990) 1.25
Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies. J Gen Virol (1982) 1.24
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
Transfection of lysostaphin-treated cells of Staphylococcus aureus. J Virol (1969) 1.22
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis (1994) 1.18
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
Identification of Highlands J virus from a Florida horse. Am J Trop Med Hyg (1988) 1.16
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology (1985) 1.12
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol (1988) 1.10
A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol (1991) 1.10
Properties of monoclonal antibodies directed against the glycoproteins of Sindbis virus. J Gen Virol (1982) 1.09
Stability of St. Louis encephalitis viral antigen detected by enzyme immunoassay in infected mosquitoes. J Clin Microbiol (1988) 1.08
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology (1991) 1.05
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus. Am J Trop Med Hyg (1988) 1.04
Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology (1995) 1.02
Emergence of epidemic O'nyong-nyong fever in southwestern Uganda, after an absence of 35 years. Emerg Infect Dis (1997) 1.02
Hepatitis delta virus infection in Bombay. Trans R Soc Trop Med Hyg (1992) 1.01
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol (1988) 1.01
Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia. Am J Trop Med Hyg (1988) 1.00
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol (1993) 1.00
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Virology (1990) 0.97
West Nile virus. JAMA (2001) 0.94
Evaluation of clinical specimens for the presence of respiratory syncytial virus antigens using an enzyme immunoassay. J Med Virol (1986) 0.94
Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins. J Gen Virol (1988) 0.93
Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex. Am J Trop Med Hyg (1998) 0.92
Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human. J Clin Microbiol (1990) 0.91
New treatment for herpes simplex virus type 2 [ultrasound and zinc, urea and tannic acid ointment]. Part II: Female patients. J Med (1980) 0.89
Effect of glycl-tRNA concentration on in vitro serine incorporation into the peptidoglycan of S. epidermidis. Biochem Biophys Res Commun (1973) 0.89
T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. J Virol (1991) 0.88
Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus. J Gen Virol (1990) 0.86
In vitro incorporation of serine into the staphylococcal cell wall. Infect Immun (1974) 0.85
Specificity of the murine T helper cell immune response to various alphaviruses. J Gen Virol (1989) 0.85
Treatment of genital herpes simplex virus in male patients. Arch Androl (1980) 0.84
Detection of eastern equine encephalitis virus in infected mosquitoes using a monoclonal antibody-based antigen-capture enzyme-linked immunosorbent assay. Am J Trop Med Hyg (2001) 0.81
Defined epitope blocking with Murray Valley encephalitis virus and monoclonal antibodies: laboratory and field studies. J Med Virol (1990) 0.81
Comparison of the immunogenicity of reduced doses of two recombinant DNA hepatitis B vaccines in New Zealand children. J Med Virol (1989) 0.81
Characteristics of a persistent rubella infection in a human cell line. J Gen Virol (1981) 0.80
St. Louis encephalitis virus temperature-sensitive mutants. I. Induction, isolation and preliminary characterization. Arch Virol (1983) 0.79
Anaerobic transfer of antibiotic resistance from Pseudomonas aeruginosa. Appl Environ Microbiol (1980) 0.78
Differentiation of parapoxviruses by application of orf virus-specific monoclonal antibodies against cell surface proteins. Vet Immunol Immunopathol (1991) 0.78
Edman degradation on in vitro biosynthesized peptidoglycans from Staphylococcus epidermidis. J Bacteriol (1973) 0.76
Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice. J Neurovirol (2009) 0.76
A combined chemical-physical treatment for herpes simplex lesions in guinea pigs. Arch Dermatol Res (1979) 0.76
Effect of triethylenetetramine dihydrochloride on the antibiotic susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1978) 0.75
A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes. J Virol (1992) 0.75
Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus. Hybridoma (1999) 0.75
Hepatitis B-like infection in a Pacific white-sided dolphin (Lagenorhynchus obliquidens). J Am Vet Med Assoc (1990) 0.75
Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus. Vaccine (1994) 0.75
A comparison of Saint Louis encephalitis and Sindbis virus RNA. Arch Virol (1977) 0.75
Laboratory testing for West Nile virus: panel discussion. Ann N Y Acad Sci (2001) 0.75
Genetic exclusion and stable complementation of Sindbis virus. Arch Virol (1976) 0.75
The effect of triethylenetetramine dihydrochloride on the in vivo susceptibility of Pseudomonas aeruginosa to gentamicin. J Antibiot (Tokyo) (1979) 0.75